|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$2.80 |
$2.84 |
$2.56 |
$2.69 |
697.90K | 03/25/2024 |
$2.70 |
$2.99 |
$2.67 |
$2.82 |
1.08M | 03/26/2024 |
$2.84 |
$3.00 |
$2.67 |
$2.85 |
832.90K | 03/27/2024 |
$2.88 |
$3.00 |
$2.73 |
$2.88 |
887.00K | 03/28/2024 |
$2.81 |
$2.93 |
$2.80 |
$2.88 |
809.00K |
|
Regulus Therapeutics is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat diseases. Co.'s key product candidates are RG-012 and RGLS4326. RG-012 is an anti-miR targeting miR-21 for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. Co. has multiple programs in various stages of preclinical development including RGLS5579 as a clinical candidate in its glioblastoma multiforme program, its preclinical programs targeting the Hepatitis B virus and Non-Alcoholic Steatohepatitis program. | |
|
Regulus Therapeutics (RGLS) has the following price history information. Looking back at RGLS historical stock prices for the last five trading days, on March 22, 2024, RGLS opened at $2.80, traded as high as $2.84 and as low as $2.56, and closed at $2.69. Trading volume was a total of 697.90K shares. On March 25, 2024, RGLS opened at $2.70, traded as high as $2.99 and as low as $2.67, and closed at $2.82. Trading volume was a total of 1.08M shares. On March 26, 2024, RGLS opened at $2.84, traded as high as $3.00 and as low as $2.67, and closed at $2.85. Trading volume was a total of 832.90K shares. On March 27, 2024, RGLS opened at $2.88, traded as high as $3.00 and as low as $2.73, and closed at $2.88. Trading volume was a total of 887.00K shares. On March 28, 2024, RGLS opened at $2.81, traded as high as $2.93 and as low as $2.80, and closed at $2.88. Trading volume was a total of 809.00K shares.
RGLS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Regulus Therapeutics shares, starting with a $10,000 purchase of RGLS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$1,030.80 |
|
End price/share: |
$2.88 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.72% |
|
Average Annual Total Return: |
-44.47% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$27.92 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $2.69 | 03/25/2024 | $2.82 | 03/26/2024 | $2.85 | 03/27/2024 | $2.88 | 03/28/2024 | $2.88 |
|
|